Patton Fund Management’s Gilead Sciences GILD Stock Holding History

Patton Fund Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,594	Closed	-$3.01M	–	249
2026 Q1	$3.01M	Sell	21,594 -38,011	-64%	-$5.32M	0.51%	55
2025 Q4	$7.32M	Buy	59,605 +57,471	+2,693%	+$6.98M	0.98%	33
2025 Q3	$237K	Hold	2,134	–	–	0.04%	317
2025 Q2	$237K	Buy	+2,134	New	+$227K	0.05%	266
2023 Q1	–	Sell	-2,417	Closed	-$207K	–	146
2022 Q4	$207K	Buy	+2,417	New	+$191K	0.06%	156
2020 Q3	–	Sell	-15,147	Closed	-$1.17M	–	84
2020 Q2	$1.17M	Sell	15,147 -3,234	-18%	-$248K	0.68%	52
2020 Q1	$1.37M	Buy	+18,381	New	+$1.27M	0.85%	39

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Patton Fund Management's GILD Position: Q2 2026 in Review

Patton Fund Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 21,594 shares — an estimated $3.01M sold.

Patton Fund Management first reported a position in GILD in Q1 2020 and held it in 7 quarters. The position peaked at $7.32M in Q4 2025. 486 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Patton Fund Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Patton Fund Management sold 21,594 Gilead Sciences shares in Q2 2026, an estimated $3.01M.
Patton Fund Management first reported a position in Gilead Sciences in Q1 2020 and held it in 7 quarters.
Patton Fund Management's Gilead Sciences position peaked at $7.32M in Q4 2025.
486 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.